CRNX
Crinetics Pharmaceuticals Inc
$56.09
Earnings Summary
Revenue | $0Mn |
Net Profits | $-76.83Mn |
Net Profit Margins | -Inf% |
Highlights
Crinetics Pharmaceuticals Inc’s revenue fell -100% since last year same period to $0Mn in the Q3 2024. On a quarterly growth basis, Crinetics Pharmaceuticals Inc has generated -100% fall in its revenue since last 3-months.
Crinetics Pharmaceuticals Inc’s net profit fell -33.71% since last year same period to $-76.83Mn in the Q3 2024. On a quarterly growth basis, Crinetics Pharmaceuticals Inc has generated -3.74% fall in its net profits since last 3-months.
Crinetics Pharmaceuticals Inc’s net profit margin fell -Inf% since last year same period to -Inf% in the Q3 2024. On a quarterly growth basis, Crinetics Pharmaceuticals Inc has generated -Inf% fall in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the Crinetics Pharmaceuticals Inc post its latest quarter earnings
EPS Estimate Current Quarter | -0.91 |
EPS Estimate Current Year | -0.91 |
Highlights
Crinetics Pharmaceuticals Inc’s earning per share (EPS) estimates for the current quarter stand at -0.91 - a -5.81% fall from last quarter’s estimates.
Crinetics Pharmaceuticals Inc’s earning per share (EPS) estimates for the current year stand at -0.91.
Key Ratios
Key ratios of the Crinetics Pharmaceuticals Inc post its Q3 2024 earnings
Earning Per Share (EPS) | -0.96 |
Highlights
Crinetics Pharmaceuticals Inc’s earning per share (EPS) jumped 4.95% since last year same period to -0.96 in the Q3 2024. This indicates that the Crinetics Pharmaceuticals Inc has generated 4.95% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2024-05-09 | -0.81 | -0.93 | -14.81% |
2024-11-12 | -0.91 | -0.96 | -5.49% |
2024-08-08 | -0.86 | -0.94 | -9.3% |
₹0 US Stocks a/c Opening Fee